Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 1
Journal homepage
151
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature

Hideaki Tsujia Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-2521-246X
ORCID Icon,
Hajime Yoshifujia Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7082-4900
ORCID Icon,
Takero Shindob Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-2085-6151
ORCID Icon,
Masakatsu Hishizawab Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Ayami Ishidac Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Masakazu Fujimotoc Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Koji Kitagoria Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Shuji Akizukia Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Kosaku Murakamia Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0001-5981-4648
ORCID Icon,
Ran Nakashimaa Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Motomu Hashimotod Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Masao Tanakad Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, JapanORCID Iconhttps://orcid.org/0000-0002-8942-2933
ORCID Icon &
Koichiro Ohmuraa Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
 show all
Pages 172-177 | Received 16 Jul 2020, Accepted 04 Sep 2020, Published online: 22 Oct 2020

References

  • Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.
  • Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6):1943–1949.
  • Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007;56(5):1433–1439.
  • Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91(1):20–28.
  • Fukasawa M, Akazawa Y, Kasugai S, et al. [Four cases of other iatrogenic immunodeficiency-associated Lymphoproliferative disorders in the head and neck region]. Nippon Jibiinkoka Gakkai Kaiho. 2016;119(5):741–749.
  • Yamakawa N, Fujimoto M, Kawabata D, et al. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders. J Rheumatol. 2014;41(2):293–299.
  • Yamada K, Oshiro Y, Okamura S, et al. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Histopathology. 2015;67(1):70–80.
  • Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34(2):322–331.
  • Page RD, Romaguera JE, Osborne B, et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer. 2001;92(8):2023–2029.
  • Noronha V, Shafi NQ, Obando JA, et al. Primary non-Hodgkin’s lymphoma of the liver. Crit Rev Oncol Hematol. 2005;53(3):199–207.
  • Soubrier M, Arrestier S, Bouloudian S, et al. Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis. Joint Bone Spine. 2006;73(2):218–219.
  • Tatsumi G, Ukyo N, Hirata H, et al. Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate. Case Rep Hematol. 2014;2014:460574.
  • Kawahara A, Tsukada J, Yamaguchi T, et al. Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma. Biomark Res. 2015;3:10.
  • Miyagawa K, Shibata M, Noguchi H, et al. Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. Intern Med. 2015;54(4):401–405.
  • Takei D, Abe T, Amano H, et al. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: a case report. Int J Surg Case Rep. 2017;31:5–9.
  • Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
  • Arber JM, Weiss LM, Chang KL, et al. The effect of decalcification on in situ hybridization. Mod Pathol. 1997;10(10):1009–1014.
  • Qi ZL, Han XQ, Hu J, Wang GH, et al. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin’s lymphoma in paraffin-embedded tissues. Mol Med Rep. 2013;7(1):89–92.
  • Kikuma K, Watanabe J, Oshiro Y, et al. Etiological factors in primary hepatic B-cell lymphoma. Virchows Arch. 2012;460(4):379–387.
  • Kurita D, Miyoshi H, Ichikawa A, et al. Methotrexate-associated Lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors. Am J Surg Pathol. 2019;43(7):869–884.
  • Rezk SA, Zhao X, Weiss LM. Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update. Hum Pathol. 2018;79:18–41.
  • Baecklund E, Smedby KE, Sutton LA, et al. Lymphoma development in patients with autoimmune and inflammatory disorders-what are the driving forces? Semin Cancer Biol. 2014;24:61–70.
  • Saito S, Suzuki K, Yoshimoto K, et al. Restoration of decreased T helper 1 and CD8+ T cell subsets is associated with regression of Lymphoproliferative disorders developed during methotrexate treatment. Front Immunol. 2018;9:621.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.